We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-13.64%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$42.3B
AUM Growth
-$25.4B
Cap. Flow
-$18.9B
Cap. Flow %
-44.7%
Top 10 Hldgs %
18.81%
Holding
4,572
New
126
Increased
1,431
Reduced
2,296
Closed
248

Sector Composition

Rank Sector Weight
1 Technology 7%
2 Financials 5.86%
3 Healthcare 5.05%
4 Consumer Discretionary 4.98%
5 Industrials 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNT
3876
AGNT Inc
AGNT
$752M
$658 ﹤0.01%
+186
New +$1.04K
AQB icon
3877
AquaBounty Technologies
AQB
$7.72M
$648 ﹤0.01%
16
CURO
3878
DELISTED
CURO Group Holdings Corp.
CURO
$645 ﹤0.01%
68
-176
-72% -$2.88K
MACK
3879
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$633 ﹤0.01%
208
+39
+23% +$135
RUBY
3880
DELISTED
Rubius Therapeutics, Inc
RUBY
$627 ﹤0.01%
39
-13
-25% -$237
PCMI
3881
DELISTED
PCM, Inc
PCMI
$616 ﹤0.01%
35
RNGR icon
3882
Ranger Energy Services
RNGR
$405M
$610 ﹤0.01%
118
APTI
3883
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$607 ﹤0.01%
16
-1,072
-99% -$36.2K
OVID icon
3884
Ovid Therapeutics
OVID
$523M
$605 ﹤0.01%
250
-172
-41% -$785
PFIE
3885
DELISTED
Profire Energy, Inc
PFIE
$599 ﹤0.01%
413
-360
-47% -$838
ZAGG
3886
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$597 ﹤0.01%
61
-9,172
-99% -$103K
ACGN
3887
DELISTED
Aceragen Inc
ACGN
$593 ﹤0.01%
13
-16
-55% -$1.84K
AAC
3888
DELISTED
AAC Holdings
AAC
$589 ﹤0.01%
421
-18
-4% -$72
MB
3889
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$582 ﹤0.01%
16
-1,404
-99% -$42.7K
GDP
3890
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$580 ﹤0.01%
43
-240
-85% -$3.38K
KG
3891
Kestrel Group
KG
$60.5M
$571 ﹤0.01%
17
-227
-93% -$12.2K
HZN
3892
DELISTED
Horizon Global Corporation
HZN
$571 ﹤0.01%
399
CRD.A icon
3893
Crawford & Co Class A
CRD.A
$632M
$570 ﹤0.01%
64
-231
-78% -$2.08K
QTRX icon
3894
Quanterix
QTRX
$135M
$568 ﹤0.01%
31
-127
-80% -$2.28K
DEO icon
3895
Diageo
DEO
$52.8B
$567 ﹤0.01%
4
-6
-60% -$844
GERN icon
3896
Geron
GERN
$982M
$561 ﹤0.01%
561
-115,162
-100% -$175K
SURF
3897
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$547 ﹤0.01%
129
-109
-46% -$842
III icon
3898
Information Services Group
III
$250M
$534 ﹤0.01%
126
-889
-88% -$3.74K
CLSD
3899
DELISTED
Clearside Biomedical
CLSD
$526 ﹤0.01%
33
-28
-46% -$1.31K
NES
3900
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$525 ﹤0.01%
64
+22
+52% +$216

Similar funds

BNP Paribas Financial Markets's Q4 2018 Portfolio in Review

As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.

  • BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
  • BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
  • BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
  • BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
  • BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
  • BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.